ArticleACS omega2026
Design of a Low-Decomposition-Temperature Polyurethane Foam.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, we describe polyurethane foams designed to degrade at relatively low temperatures, incorporating polypropylene carbonate polyols as well as novel polycarbonates designed for low-temperature degradation. Polyurethane foams formed using degradable polyols and typical water/MDI blowing agents showed poor degradation performance. Significantly better degradation performance was observed in foams formulated to use a minimum of water/isocyanate blowing agent. Degradation performance was also improved by the inclusion of a strong acid catalyst and the use of aliphatic isocyanates in place of aromatic isocyanates. These degradable polyurethane foams may have applications in low-waste packaging or packaging of hazardous materials.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.